BioSpace News Archive

Pharm Country

NCCN Publishes First-Ever U.S. Guidelines for Rare Cancers Associated with Pregnancy

The National Comprehensive Cancer Network® (NCCN®) has released new treatment guidelines for a group of rare cancers that impact women during pregnancy.

August 9, 2018
·
6 min read
Policy

MiMedx Receives Regulatory Approval to Commercialize Product Portfolio in Australia

Partners with Leading Australian Healthcare Products and Biological Supplier

August 9, 2018
·
4 min read
FDA

US Food and Drug Administration Approves ARAKODA™ (tafenoquine) tablets for oral use; First preventative antimalarial approved in almost two decades

60° Pharmaceuticals (60P) announced today the Food and Drug Administration (FDA) approval of ARAKODA™ (tafenoquine) tablets for the prevention of malaria in patients aged 18 years and older.

August 9, 2018
·
6 min read
Business

GRAIL Announces Appointment of Hal Barron and Hans Bishop to its Board of Directors

GRAIL, Inc. announced the appointment of Hal Barron, MD, and Hans Bishop to its Board of Directors.

August 9, 2018
·
2 min read
Drug Development

CBT Pharmaceuticals Receives First Australian Ethics Approval to Initiate APOLLO-1 Phase 1/2 Clinical Trial for Hepatocellular and Renal Cell Carcinoma

CBT Pharmaceuticals (CBT), a U.S. and China-based innovative biopharmaceutical company committed to becoming a leader in the discovery and development of oncology combination therapies, today announced the receipt of ethics approval from the Bellberry Human Research Ethics Committee (HREC) in Australia for its planned APOLLO-1 clinical trial.

August 9, 2018
·
3 min read
Business

Zomedica Pharmaceuticals Corp. Announces Second Quarter 2018 Financial Results

Zomedica Pharmaceuticals Corp. reported consolidated financial results for the second quarter ended June 30, 2018.

August 9, 2018
·
9 min read
Business

Cyclacel Pharmaceuticals Reports Second Quarter 2018 Financial Results

Cyclacel Pharmaceuticals, Inc. reported financial results and business highlights for the second quarter 2018.

August 9, 2018
·
9 min read
Business

Kindred Biosciences Announces Second Quarter 2018 Financial Results

Kindred Biosciences, Inc. announced financial results for the second quarter ended June 30, 2018 and provided updates on its programs.

August 9, 2018
·
16 min read
Business

Endologix Reports Second Quarter 2018 Financial Results

Endologix, Inc. announced financial results for the second quarter ended June 30, 2018.

August 9, 2018
·
13 min read
Business

Magenta Therapeutics Reports Recent Operational Progress and Second Quarter 2018 Financial Results

Transplanted first patient with MGTA-456 in Phase 2 study in inherited metabolic disorders

August 9, 2018
·
7 min read